Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP38 inhibits ZIKV N mRNA NS5 mRNA. 1 / 1

| 1

➶

eidos

"Immunoblot analyses indicated that the levels of ZIKV E protein and NS5 protein were significantly attenuated by USP38 , but not by USP38-MUT ( Figure 4B ) , and similarly , qPCR results revealed that the levels of ZIKV N mRNA and NS5 mRNA ( Figure 4C ) as well as ZIKV RNA ( Figure 4D ) were significantly reduced by USP38 , but relatively unaffected by USP38-MUT ."

| PMC

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...